Edwards Lifesciences (EW) holder Wayne Markowitz reports recent stock sales

Rhea-AI Filing Summary

Wayne Markowitz, associated with Edwards Lifesciences Corp (EW), filed a notice of intent to sell common stock. Recent sale history shows transactions of 593 shares for $47,280.00 on May 11, 2026, and 9,628 shares for $818,958.00 on July 28, 2026.

Key Figures

Shares sold: 593 shares Proceeds from sale: $47,280.00 Shares sold: 9,628 shares +1 more

4 metrics

Shares sold 593 shares Common stock sale on 05/11/2026

Proceeds from sale $47,280.00 Aggregate amount for 593 shares sold on 05/11/2026

Shares sold 9,628 shares Common stock sale on 07/28/2026

Proceeds from sale $818,958.00 Aggregate amount for 9,628 shares sold on 07/28/2026

Key Terms

Form 144, ESPP, Securities To Be Sold

3 terms

Form 144 regulatory

"144: Securities Sold During The Past 3 Months"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

ESPP financial

"Common | 03/28/2024 | ESPP - See Remarks"

An Employee Stock Purchase Plan (ESPP) is a company program that lets employees buy the company’s shares at a reduced price, usually by setting aside a small portion of their pay over time. It matters to investors because it encourages employees to own part of the business—like giving staff a discounted membership— which can boost commitment and performance, while also potentially increasing the number of shares available and affecting shareholder value.

Securities To Be Sold regulatory

"144: Securities To Be Sold"

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 07/30/2026 - 04:19 PM Accepted by SEC EDGAR 07/30/2026 - 04:19 PM Learn about SEC filing dates

FAQ

What does Edwards Lifesciences (EW) disclose in this Form 144 notice?

The filing shows Wayne Markowitz providing notice of intent to sell Edwards Lifesciences common stock, along with details of common stock sales made in the preceding three months, including share counts and dollar amounts.

How many Edwards Lifesciences (EW) shares did Wayne Markowitz sell recently?

The filing lists sales of 593 shares on May 11, 2026 and 9,628 shares on July 28, 2026. These transactions are reported as part of the three‑month sales history required in a Form 144 notice.

What were the dollar amounts of recent Edwards Lifesciences (EW) stock sales?

The sales reported include $47,280.00 for 593 shares on May 11, 2026 and $818,958.00 for 9,628 shares on July 28, 2026. These figures reflect the aggregate sale proceeds for each reported transaction.

Which broker is listed for the Edwards Lifesciences (EW) stock in this filing?

The broker listed in connection with the common stock is Charles Schwab & Co., Inc. located in Westlake, Texas. This broker information appears in the section describing the common stock to be sold.

What type of Edwards Lifesciences (EW) security is referenced in this Form 144?

The notice concerns common stock of Edwards Lifesciences Corp. The form identifies the security type as common and provides related broker and marketplace details, including a reference to listing on the NYSE.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Charles Schwab & Co., Inc. 3000 Schwab Way Westlake TX 76262	147	12588.00	575800000	07/30/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/28/2024	ESPP - See Remarks	EDWARDS LIFESCIENCES CORPORATION			147	03/28/2024	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
WAYNE MARKOWITZ ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	05/11/2026	593	47280.00
WAYNE MARKOWITZ ONE EDWARDS WAY IRVINE CA 92614	Edwards Lifesciences Corp	07/28/2026	9628	818958.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)